Delhi High Court granted US drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans
Read More
US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans
Read More
A powerful antibiotic combination that is marketed in India by US pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities
Read More
Andhra Pradesh Chief Minister Chandrababu Naidu says the King's College Hospital has agreed to set up a 1,000-bed hospital in new capital Amaravati and plans to set up 11 hospitals in different parts of India
Read More
Domestic companies grew at a modest pace of 14 per cent as against 19.4 per cent in the same period last year, and an average of 13.3 per cent since April 2015
Read More
In 2014, India set up a committee to review more than 6,000 combinations that had entered the market based only on state regulators' approval
Read More
If government granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports
Read More
Teva will gain bigger economies of scale, a crucial element in the low-margin generic drugs business, with the deal, the largest in Israel's corporate history.
Read More
